Company Description
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China.
It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.
Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners.
In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel.
Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment.
Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services.
Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
Country | China |
IPO Date | Dec 11, 2009 |
Industry | Medical Care Facilities |
Sector | Healthcare |
Employees | 727 |
CEO | Dr. Jianyu Yang |
Contact Details
Address: Room 26a1-26a5, East Tower, Hanwei, Building No. 7 Guanghua Road Chaoyang District, Beijing, F4 100020 China | |
Phone | (86)10-5825-6867 |
Website | concordmedical.com |
Stock Details
Ticker Symbol | CCM |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | CNY |
CIK Code | 0001472072 |
CUSIP Number | 206277105 |
ISIN Number | US2062771058 |
SIC Code | 8011 |
Key Executives
Name | Position |
---|---|
Dr. Jianyu Yang | Chairman and Chief Executive Officer |
Boxun Zhang | Chief Financial Officer |
Xun Liu | Financial Controller |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 30, 2024 | 6-K | Report of foreign issuer |
Apr 26, 2024 | 6-K | Report of foreign issuer |
Apr 19, 2024 | 6-K | Report of foreign issuer |
Apr 19, 2024 | 20-F | Annual and transition report of foreign private issuers |
Mar 27, 2024 | 6-K | Report of foreign issuer |
Feb 20, 2024 | 6-K | Report of foreign issuer |
Jan 9, 2024 | 6-K | Report of foreign issuer |
Nov 20, 2023 | 6-K | Report of foreign issuer |
Sep 22, 2023 | 6-K | Report of foreign issuer |
Apr 20, 2023 | 6-K | Report of foreign issuer |